Liu et al10 performed IHC for CD8 staining in 3992 breast cancer samples and demonstrated that in TN patients, intratumoral or stromal infiltration by CD8‐positive lymphocytes is an independent favorable prognostic factor for BC‐specific survival (BCSS). The gene discussed is CD8A; the disease is breast cancer.